More Diagnostics

More Diagnostics is a long-established, employee-owned provider of high-quality clinical diagnostic controls, with roots dating back to 1985. The company leverages its in-house R&D and manufacturing to produce stable, human-based control materials that ensure laboratory test accuracy and regulatory compliance for partners worldwide. Its core business spans supplying OEM manufacturers, offering cost-effective third-party controls to labs, developing custom/private label products, and providing a quality assurance program (QAP) for peer comparison. With key certifications including ISO 13485 and FDA licensing, More Diagnostics is a trusted partner in a critical, niche segment of the diagnostics market.

Proprietary formulation and stabilization of liquid, human-based (whole blood and serum) control materials for in vitro diagnostic quality assurance. Expertise in creating commutable controls that behave like patient samples across analytical phases.

More Diagnostics competes in the niche quality control segment against large, diversified players like Bio-Rad and Siemens Healthineers, which offer broad control portfolios, as well as other specialized control manufacturers. Its differentiation lies in its deep expertise in human-based, liquid controls for specialized assays like immunosuppressant monitoring and its flexible OEM/contract manufacturing services.